CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.
Hypoxia-inducible factors, HIF-1α and HIF-2α, are expressed in the majority of clear-cell renal cell carcinoma (CC-RCC). In vitro, HIFα isoforms regulate a differential set of genes, and their effects in vivo within CC-RCC tumours may affect outcome. The role of angiogenesis and HIFα transcriptional...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797065093277548544 |
|---|---|
| author | Biswas, S Charlesworth, P Turner, G Leek, R Thamboo, P Campo, L Turley, H Dildey, P Protheroe, A Cranston, D Gatter, K Pezzella, F Harris, A |
| author_facet | Biswas, S Charlesworth, P Turner, G Leek, R Thamboo, P Campo, L Turley, H Dildey, P Protheroe, A Cranston, D Gatter, K Pezzella, F Harris, A |
| author_sort | Biswas, S |
| collection | OXFORD |
| description | Hypoxia-inducible factors, HIF-1α and HIF-2α, are expressed in the majority of clear-cell renal cell carcinoma (CC-RCC). In vitro, HIFα isoforms regulate a differential set of genes, and their effects in vivo within CC-RCC tumours may affect outcome. The role of angiogenesis and HIFα transcriptional products, including those involved in cell metabolism and morphological dedifferentiation have not been extensively investigated and might have relevance to the development of antiangiogenic or anti-HIFα trials in primary CC-RCC, either before or after radical nephrectomy. We analysed 168 consecutive clear-cell renal tumours from 1983 to 1999 within tissue microarrays and assessed expression of HIF-1α and HIF-2α together with the protein expression of seven of their target genes (BNIP3, CA9, Cyclin D1, GLUT-1, LDH5, Oct-4 and VEGF). The expression of these factors was compared with patient overall survival and CD31 angiogenesis. We found that HIFα antigenicity deteriorated with the age of the paraffin block (P < 0.0001) and in tumours from 1983 to 1992 was deemed not to be reliable. Similar findings were found in aged archival osteosarcoma samples. This might have important implications for retrospective biomarker studies that rely on archival tissue material. HIF-1α(HIGH)/HIF-2α(LOW) tumours had a worse overall survival compared with HIF-1α(LOW)/HIF-2α(LOW) tumours (P = 0.04). Surprisingly, on multivariate analysis, high levels of CD31(+) angiogenesis was shown to be an independent prognostic marker of increased overall survival (P = 0.003). We propose that better differentiation of vascular endothelium may be a reflection of a greater production of vessel stabilization factors versus pro-angiogenic factors, and therefore a less aggressive phenotype. |
| first_indexed | 2024-03-06T21:23:43Z |
| format | Journal article |
| id | oxford-uuid:425ae9b8-735b-435e-8818-8bb922773d65 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:23:43Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:425ae9b8-735b-435e-8818-8bb922773d652022-03-26T14:49:00ZCD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:425ae9b8-735b-435e-8818-8bb922773d65EnglishSymplectic Elements at Oxford2012Biswas, SCharlesworth, PTurner, GLeek, RThamboo, PCampo, LTurley, HDildey, PProtheroe, ACranston, DGatter, KPezzella, FHarris, AHypoxia-inducible factors, HIF-1α and HIF-2α, are expressed in the majority of clear-cell renal cell carcinoma (CC-RCC). In vitro, HIFα isoforms regulate a differential set of genes, and their effects in vivo within CC-RCC tumours may affect outcome. The role of angiogenesis and HIFα transcriptional products, including those involved in cell metabolism and morphological dedifferentiation have not been extensively investigated and might have relevance to the development of antiangiogenic or anti-HIFα trials in primary CC-RCC, either before or after radical nephrectomy. We analysed 168 consecutive clear-cell renal tumours from 1983 to 1999 within tissue microarrays and assessed expression of HIF-1α and HIF-2α together with the protein expression of seven of their target genes (BNIP3, CA9, Cyclin D1, GLUT-1, LDH5, Oct-4 and VEGF). The expression of these factors was compared with patient overall survival and CD31 angiogenesis. We found that HIFα antigenicity deteriorated with the age of the paraffin block (P < 0.0001) and in tumours from 1983 to 1992 was deemed not to be reliable. Similar findings were found in aged archival osteosarcoma samples. This might have important implications for retrospective biomarker studies that rely on archival tissue material. HIF-1α(HIGH)/HIF-2α(LOW) tumours had a worse overall survival compared with HIF-1α(LOW)/HIF-2α(LOW) tumours (P = 0.04). Surprisingly, on multivariate analysis, high levels of CD31(+) angiogenesis was shown to be an independent prognostic marker of increased overall survival (P = 0.003). We propose that better differentiation of vascular endothelium may be a reflection of a greater production of vessel stabilization factors versus pro-angiogenic factors, and therefore a less aggressive phenotype. |
| spellingShingle | Biswas, S Charlesworth, P Turner, G Leek, R Thamboo, P Campo, L Turley, H Dildey, P Protheroe, A Cranston, D Gatter, K Pezzella, F Harris, A CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. |
| title | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. |
| title_full | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. |
| title_fullStr | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. |
| title_full_unstemmed | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. |
| title_short | CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. |
| title_sort | cd31 angiogenesis and combined expression of hif 1α and hif 2α are prognostic in primary clear cell renal cell carcinoma cc rcc but hifα transcriptional products are not implications for antiangiogenic trials and hifα biomarker studies in primary cc rcc |
| work_keys_str_mv | AT biswass cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT charlesworthp cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT turnerg cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT leekr cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT thamboop cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT campol cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT turleyh cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT dildeyp cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT protheroea cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT cranstond cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT gatterk cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT pezzellaf cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc AT harrisa cd31angiogenesisandcombinedexpressionofhif1aandhif2aareprognosticinprimaryclearcellrenalcellcarcinomaccrccbuthifatranscriptionalproductsarenotimplicationsforantiangiogenictrialsandhifabiomarkerstudiesinprimaryccrcc |